O

Optimed Research, LTD | Optimed Research, LTD

Research site
(Unclaimed)
Location
8000 Ravines Edge Ct Suite 200, Columbus, Ohio, United States of America
Site insights

Top conditions

Hereditary Angioedemas (8 trials)

Angioedema (8 trials)

Immunologic Deficiency Syndromes (4 trials)

Primary Immunodeficiency Diseases (4 trials)

Osteoarthritis (3 trials)

Top treatments

Lanadelumab
Bococizumab
BLU-5937
Mirikizumab
Tanezumab
NX-13
LY3454738
KALBITOR
Methotrexate
GLPG1972

Parent organization

This site is a part of Optimed Research, LTD

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 24
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough (CALM-2)

This is a randomized, double-blind, placebo-controlled, parallel-arm, Phase 3 study of BLU-5937 in participants with Refractory Chronic Cough (RCC).

Enrolling
Refractory Chronic Cough
Drug: BLU-5937
Drug: Placebo

This is a Phase 1/2, single-arm, open-label, dose-escalation and dose-expansion study of BMN 331 for the treatment of hereditary angioedema (HAE) due...

Enrolling
HAE
Hereditary Angioedema
Genetic: Dose 6 of BMN 331
Genetic: Dose 2 of BMN 331

The main aim of this study is to evaluate the PK, safety, tolerability and immunogenicity of subcutaneous (SC) administration of TAK-881 in adult and...

Enrolling
Primary Immunodeficiency Diseases (PID)
Biological: HYQVIA
Biological: TAK-881

A study to investigate bowel urgency in adults with moderately to severely active ulcerative colitis (UC) treated with mirikizumab. The study will ha...

Enrolling
Ulcerative Colitis Chronic
Ulcerative Colitis
Drug: Mirikizumab

Primary Objective:To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary...

Active, not recruiting
Chronic Obstructive Pulmonary Disease
Drug: Placebo
Drug: Inhaled Long-Acting Muscarinic Antagonist

Trial sponsors

Shire logo

Shire (5 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems